Excelsior Medical Co., Ltd.(TW:4104)
NT$72.00-0.10 (-0.14%)
TW:4104
Excelsior Medical Co., Ltd. financials statements
NT$72.00
At close:-0.10 (-0.14%)
Excelsior Medical Co., Ltd. (4104) Ratios
Excelsior Medical Co., Ltd. Ratios
TW:4104's free cash flow for Q2 2026 was NT$290.33M. For the 2026 fiscal year, TW:4104's free cash flow was decreased by NT$-31.28M and operating cash flow was NT$321.61M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.67 | 1.47 | 1.60 | 1.66 | 1.88 |
| Quick Ratio | 1.45 | 1.31 | 1.41 | 1.45 | 1.69 |
| Cash Ratio | 0.46 | 0.51 | 0.39 | 0.44 | 0.62 |
| Solvency Ratio | 0.15 | 0.12 | 0.14 | 0.14 | 0.15 |
| Operating Cash Flow Ratio | -0.19 | 0.30 | 0.02 | 0.11 | 0.19 |
| Short-Term Operating Cash Flow Coverage | -0.88 | 2.69 | 0.09 | 1.19 | 1.97 |
| Net Current Asset Value | NT$ 3.11B | NT$ 3.21B | NT$ 3.52B | NT$ 3.34B | NT$ 3.95B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.11 | 0.07 | 0.08 | 0.05 | 0.05 |
| Debt-to-Equity Ratio | 0.24 | 0.16 | 0.17 | 0.10 | 0.10 |
| Debt-to-Capital Ratio | 0.19 | 0.14 | 0.14 | 0.09 | 0.09 |
| Long-Term Debt-to-Capital Ratio | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.06 | 2.27 | 2.10 | 2.01 | 1.95 |
| Debt Service Coverage Ratio | 0.60 | 1.03 | 0.65 | 1.86 | 1.91 |
| Interest Coverage Ratio | 21.19 | 27.65 | 40.87 | 83.25 | 87.80 |
| Debt to Market Cap | 0.10 | 0.07 | 0.09 | 0.06 | 0.06 |
| Interest Debt Per Share | 10.51 | 8.47 | 8.94 | 5.01 | 4.72 |
| Net Debt to EBITDA | -0.66 | -2.34 | -1.21 | -1.42 | -2.13 |
| Profitability Margins | |||||
| Gross Profit Margin | 21.31% | 20.86% | 20.28% | 21.07% | 20.90% |
| EBIT Margin | 8.42% | 10.29% | 8.54% | 13.55% | 13.43% |
| EBITDA Margin | 11.85% | 13.81% | 11.76% | 16.65% | 16.51% |
| Operating Profit Margin | 8.42% | 8.78% | 8.54% | 12.10% | 11.70% |
| Pretax Profit Margin | 13.45% | 13.75% | 13.90% | 13.41% | 13.29% |
| Net Profit Margin | 9.17% | 9.03% | 9.07% | 9.29% | 9.24% |
| Continuous Operations Profit Margin | 10.99% | 11.37% | 11.21% | 6.89% | 7.44% |
| Net Income Per EBT | 68.18% | 65.67% | 65.26% | 69.26% | 69.49% |
| EBT Per EBIT | 159.75% | 156.65% | 162.77% | 110.79% | 113.59% |
| Return on Assets (ROA) | 4.25% | 3.79% | 4.13% | 4.05% | 4.02% |
| Return on Equity (ROE) | 8.77% | 8.60% | 8.67% | 8.14% | 7.85% |
| Return on Capital Employed (ROCE) | 5.79% | 6.21% | 6.16% | 8.11% | 7.58% |
| Return on Invested Capital (ROIC) | 4.23% | 4.72% | 4.50% | 6.24% | 5.94% |
| Return on Tangible Assets | 4.26% | 3.80% | 4.14% | 4.06% | 4.03% |
| Earnings Yield | 4.81% | 5.49% | 5.69% | 6.99% | 7.84% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.69 | 1.52 | 3.61 | 0.00 | 0.00 |
| Payables Turnover | 6.07 | 6.92 | 6.75 | 5.67 | 5.49 |
| Inventory Turnover | 4.97 | 4.85 | 5.26 | 4.89 | 5.71 |
| Fixed Asset Turnover | 8.55 | 7.62 | 7.69 | 6.99 | 7.19 |
| Asset Turnover | 0.46 | 0.42 | 0.46 | 0.44 | 0.44 |
| Working Capital Turnover Ratio | 2.17 | 2.15 | 2.11 | 1.77 | 1.49 |
| Cash Conversion Cycle | 229.56 | 262.14 | 116.30 | 10.37 | -2.59 |
| Days of Sales Outstanding | 216.28 | 239.68 | 101.03 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 73.44 | 75.23 | 69.37 | 74.71 | 63.90 |
| Days of Payables Outstanding | 60.16 | 52.78 | 54.10 | 64.34 | 66.49 |
| Operating Cycle | 289.72 | 314.92 | 170.40 | 74.71 | 63.90 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -5.70 | 14.41 | 0.66 | 3.90 | 5.78 |
| Free Cash Flow Per Share | -6.07 | 13.70 | -0.22 | 2.84 | 4.75 |
| Dividend Paid and CapEx Coverage Ratio | -1.70 | 3.47 | 0.16 | 0.96 | 1.43 |
| Capital Expenditure Coverage Ratio | -15.30 | 20.48 | 0.85 | 3.69 | 5.60 |
| Operating Cash Flow Coverage Ratio | -0.55 | 1.73 | 0.07 | 0.79 | 1.24 |
| Operating Cash Flow to Sales Ratio | -0.14 | 0.29 | 0.01 | 0.09 | 0.14 |
| Free Cash Flow Yield | -7.56% | 16.73% | -0.27% | 4.87% | 10.03% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 17.37 | 18.27 | 17.59 | 14.30 | 12.76 |
| Price-to-Sales (P/S) Ratio | 1.91 | 1.65 | 1.59 | 1.33 | 1.18 |
| Price-to-Book (P/B) Ratio | 1.82 | 1.57 | 1.52 | 1.16 | 1.00 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -13.22 | 5.98 | -369.50 | 20.54 | 9.97 |
| Price-to-Operating Cash Flow Ratio | -14.08 | 5.69 | 122.60 | 14.98 | 8.19 |
| Price-to-Earnings Growth (PEG) Ratio | 5.72 | -9.74 | 1.48 | 1.43 | 2.24 |
| Enterprise Value Multiple | 15.44 | 9.57 | 12.35 | 6.56 | 5.01 |
| Enterprise Value | 16.08B | 11.29B | 11.96B | 7.84B | 5.43B |
| EV to EBITDA | 15.44 | 9.57 | 12.35 | 6.56 | 5.01 |
| EV to Sales | 1.83 | 1.32 | 1.45 | 1.09 | 0.83 |
| EV to Free Cash Flow | -12.68 | 4.80 | -336.54 | 16.88 | 7.00 |
| EV to Operating Cash Flow | -13.51 | 4.57 | 111.66 | 12.31 | 5.75 |
| Tangible Book Value Per Share | 55.90 | 65.92 | 66.51 | 62.83 | 59.44 |
| Shareholders’ Equity Per Share | 44.00 | 52.28 | 52.71 | 50.19 | 47.36 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.18 | 0.17 | 0.19 | 0.19 | 0.17 |
| Revenue Per Share | 42.07 | 49.77 | 50.39 | 43.98 | 40.23 |
| Net Income Per Share | 3.86 | 4.50 | 4.57 | 4.08 | 3.72 |
| Tax Burden | 0.68 | 0.66 | 0.65 | 0.69 | 0.69 |
| Interest Burden | 1.60 | 1.34 | 1.63 | 0.99 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.13 | 0.12 | 0.12 | 0.12 | 0.12 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -1.48 | 2.10 | 0.14 | 0.66 | 1.08 |
Currency in TWD
